Early shift to oral antibiotic treatment for pyogenic vertebral osteomyelitis (SAVE): study protocol for an open label, non-inferiority, nation-wide randomized controlled clinical trial | Synapse
Early shift to oral antibiotic treatment for pyogenic vertebral osteomyelitis (SAVE): study protocol for an open label, non-inferiority, nation-wide randomized controlled clinical trial
To evaluate the effectiveness of an early shift to oral antibiotic treatment for patients with pyogenic vertebral osteomyelitis.
Open label design
Nation-wide randomized controlled trial
Non-inferiority approach to compare treatment outcomes
Expected to assess the safety and efficacy of early antibiotic treatment
Aim to show similar outcomes compared to traditional methods of treatment
Abstract
European Union Clinical Trials - EU CT Number 2023-507617-96-01: First approval 27/11/2023. Link: https://euclinicaltrials.eu/search-for-clinical-trials/?lang=en&EUCT=2023-507617-96-01.